Status:
COMPLETED
Effect of the Use of Probiotic S. Boulardii on Acute Viral Inflammatory Diarrhea Diagnosed With Multiplex PCR.
Lead Sponsor:
Instituto Mexicano del Seguro Social
Conditions:
Viral Diarrhea
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Acute diarrhea (AD) has been a public health problem throughout the history of Mexico. According to the epidemiological surveillance system, between 2008-2017, five to six million new cases of AD occu...
Detailed Description
Acute diarrhea (AD) has been a public health problem throughout the history of Mexico. According to the epidemiological surveillance system, between 2008 and 2017, five to six million new cases of AD ...
Eligibility Criteria
Inclusion
- patients who give their informed consent,
- over 18 years of age,
- leukocytes in the stool,
- confirmed diagnosis of viral infection using the multiplex PCR
Exclusion
- Confirmed diagnosis of infection by bacteria and/or parasites, associated or not with viral etiology;
- autoimmune diseases or immunosuppressive treatment;
- previous administration of antibiotic treatment during the last 7 days;
- consumption of any type of probiotic in the last 7 days;
- known allergy to probiotic containing S. boulardii;
- Inflammatory Bowel Disease;
- positive test or clinical positivity to the current operational definition for severe acute respiratory syndrome coronavirus 2 (SARS-COV-2).
- patients who do not have medical insurance.
Key Trial Info
Start Date :
December 21 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 3 2022
Estimated Enrollment :
46 Patients enrolled
Trial Details
Trial ID
NCT05226052
Start Date
December 21 2020
End Date
January 3 2022
Last Update
October 3 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hospital Puerta de Hierro Sur
Tlajomulco de Zúñiga, Jalisco, Mexico, 45640